Drug Profile
Prolixin S
Latest Information Update: 12 Dec 2006
Price :
$50
*
At a glance
- Originator Unknown
- Developer Azwell; Nonindustrial source
- Class Anticoagulants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 23 Sep 1998 No-Development-Reported for Thrombosis in Japan (Unknown route)
- 05 Jun 1996 New profile
- 05 Jun 1996 Preclinical development for Thrombosis in Japan (Unknown route)